The importance of the nasopharyngeal mucosa protection for prevention of acute respiratory viral infections and influenza in children

ARVI is the most common children infection: children aged 0–5 years suffer, on average, 6–8 episodes of ARVI per year; and in the 1–2 years of visiting kindergarten the incidence rate is higher for 10–15% than in unorganized children, and at school the latter get sick more often. The incidence of ARVI is the highest in the period from September to April and it amounts about 87–91 thousand per 100 thousand in the population. The respiratory infectious disease protection of the organism is carried out in several stages and at various levels. It primarily depends on a mechanical barrier that prevents entering the virus agent into the organism – the mucous membrane of the nasal cavity, paranasal sinuses and nasopharynx. It can be achieved due to the peculiarities of its structure – respiratory epithelium, mucociliary transport, mucus properties and lymphoid organs associated with mucous membranes. If the pathogen nevertheless penetrates this barrier, then innate immunity starts protection activity, and after that the acquired immunity activates. Antiviral protection has differences due to the structure of the virus, it’s extremely small size, and the impossibility of reproduction outside the cells. The formed immune response persists even after elimination of the pathogen in the form of immune memory, which allows a faster and stronger reaction when the pathogen reappears. Children with primary immunodeficiency, genetic, oncological, hematological diseases, bronchial asthma, chronic ENT pathology are a special risk group in terms of the frequency and severity of ARVI and influenza. In this connection, the prevention of the incidence of ARVI and influenza is extremely important.

1. Vishnyakov V.V. Otorhinolaryngology. Moscow: GEOTAR-Media; 2014. 328 p. (In Russ.).

2. Karpishchenko S.A., Bolozneva E.V., Ryazantsev S.V. Selected problems of otorhinolaryngology. Moscow: Remedium; 2021. 216 p. (In Russ.).

3. Karpishchenko S.A., Skidanova I.A. Technique of laser-induced interstitial thermotherapy in surgical treatment of nasopharyngeal diseases. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2011;17(4):30–38. (In Russ.).

4. Vereshchagina O.E., Karpishchenko S.A., Alekseeva D.A., Stancheva O.A., Rodneva Yu.A., Khalilova K.A. An approach to the management of patients with primarily detected nasopharyngeal cancer. Consilium Medicum. 2021;23(3):231–235. (In Russ.) https://doi.org/10.26442/20751753.2021.3.200584.

5. Bogomilskiy M.R., Chistyakova V.R. Pediatric otorhinolaryngology. Moscow: GEOTAR-Media; 2014. 624 p. (In Russ.).

6. Erdes S., Leonovskaya N. Rhinitis in infants. Current Pediatrics. 2009;8(4): 106–110. (In Russ.) Available at: https://vsp.spr-journal.ru/jour/article/view/1152?locale=ru_RU.

7. Volkov A.G., Trofimenko S.L. Zolotova T.V. Acute rhinitis as a manifestation of acute respiratory viral infection. Rostov-on-Don: KOPITSENTR; 2016. 96 p. (In Russ.) Available at: http://rostgmu.ru/wp-content/uploads/2020/03/%D0%A3%D1%87%D0%B5%D0%B1%D0%BD%D0%BE%D0%B5-%D0%BF%D0%BE%D1%81%D0%BE%D0%B1%D0%B8%D0%B5-.-%D0%9E%D1%81%D1%82%D1%80%D1%8B%D0%B9-%D1%80%D0%B8%D0%BD%D0%B8%D1%82..pdf.

8. Ryazantsev S.V., Khmelnitskaya N.M., Tyrnova E.V. The role of the mucous membrane in the protection of ENT organs from antigenic factors that are potentially pathogenic for the organism. Vestnik Oto¬Rino¬Laringologii. 2000;(3):60–63. (In Russ.) Available at: https://komarovskiy.net/lib/rolslizistoj-obolochki-v-zashhite-lor-organov-ot-potencialno-patogennyxdlya-organizma-antigennyx-faktorov.html.

9. Piskunov G.Z., Piskunov S.Z. Clinical rhinology. 3d ed. Мoscow: Medical Information Agency LLC; 2017. 750 p. (In Russ.) Available at: https://staticinternal.insales.ru/files/1/5876/2479860/original/klinich_rinologija.pdf.

10. Diskalenko V.V., Nikitin K.A. Chronic suppurative otitis media. St Petersburg; 2002. 18 p. (In Russ.) Available at: https://www.1spbgmu.ru/images/home/universitet/Struktura/Kafedry/Kafedra_otorinolaringology/otity.pdf.

11. Karpishchenko S.A., Vereshchagina O.E., Teplova E.О. Clinical approach to the selection of topical decongestants in paediatric otolaryngology practice. Meditsinskiy Sovet. 2019;(2):168–172. (In Russ.) https://doi.org/10.21518/2079-701X-2019-2-168-172.

12. Alekseenko S.I. Relationship between mucociliary clearance disorders and morphology of nasal mucosa in children with various forms of rhinosinusitis. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2021;27(2):4–12. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=46403834.

13. Revyakina V.A., Astafeva N.G., Ilina N.I., Geppe N.A. PRIMA: Pediatric recommendations on immunomodulatory drugs in outpatient practice. 2nd ed. Moscow: RG-Press; 2017. 80 p. (In Russ.) Available at: http://astgmu.ru/wp-content/uploads/2018/10/Pediatricheskie-rekomendatsii-poimmunomoduliruyushhim-preparatam-v-ambulatornoj-praktike-RADAR.pdf.

14. Korovina N.A., Zaplatnikov A.L., Lepiseva I.V., Ivanov V.A. General issues of managing ill children and monitoring a healthy child. Acute respiratory viral infections in the paediatric practice. Pediatrics. Consilium Medicum. 2006;8(1):19–26. (In Russ.).

15. Baranov A.A., Lobzin Yu.V., Namazova-Baranova L.S., Tatochenko V.K., Uskov A.N., Kulichenko T.V. et al. Acute Respiratory Viral Infection in Children: Modern Approaches to Diagnosis and Treatment. Pediatric Pharmacology. 2017;14(2):100–108. (In Russ.) https://doi.org/10.15690/pf.v14i2.1724.

16. Baranov A.A., Namazova-Baranova L.S., Lobzin Yu.V., Uskov A.N., Tatochenko V.K., Bakradze M.D. et al. Federal clinical guidelines for the provision of medical care to children with acute respiratory viral infection (acute nasopharyngitis). Moscow; 2015. 12 p. (In Russ.) Available at: https://minzdrav.midural.ru/uploads/%D0%BD%D0%B0%D0%B7%D0%BE%D1%84%D0%B0%D1%80%D0%B8%D0%BD%D0%B3%D0%B8%D1%82.pdf.

17. Pluzhnikov M.S., Lavrenova G.V., Katinas E.B. Basic principles of immunocorrective therapy in otorhinolaryngology. Vestnik Oto¬Rino¬Laringologii. 2008;(4):36–44. (In Russ.).

18. Shilenkova V.V. Rational approach to the diagnosis and treatment of nasopharyngeal diseases in children. Novosti zdravookhraneniya. Yaroslavl. 2002;(2):28–32. (In Russ.).

19. Svistushkin V.M., Nikiforova G.N., Vlasova N.P. Current treatment options for patients with acute respiratory viral infections. Lechaschi Vrach. 2013;(1):52. (In Russ.) Available at: https://www.lvrach.ru/2013/01/15435605.

20. Samsygina G.A. Frequently ill children: problems of pathogenesis, diagnosis, therapy. Pediatria. 2005;(1):66–74. (In Russ.) Available at: https://cyberleninka.ru/article/n/chasto-boleyuschie-deti-problemy-patogenezadiagnostiki-i-terapii/viewer.

21. Karneeva O.V. Modern possibilities for the prevention of respiratory viral infections and complications of respiratory diseases in children. Pediatrics. Consilium Medicum. 2013;(1):27–30. (In Russ.) Available at: https://omnidoctor.ru/upload/iblock/35c/35c4cce515032315323c1f524daf417a.pdf.